Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study
- PMID: 16126875
- PMCID: PMC1770812
- DOI: 10.1136/jcp.2004.022863
Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study
Abstract
Aims: To monitor the association between the course of high risk human papillomavirus (HR-HPV) infection and the development of cervical neoplasia over time, from a baseline of normal cervical cytology.
Methods: This paper presents the follow up data from a previous cross sectional analysis. Women from a screening population who had normal cytology and who were HR-HPV positive were recalled after two to three years for cytology and HPV genotyping. The development of cervical neoplasia at follow up was related to the course of HPV infection (clearance, persistence, or sequential infection) and the presence of single or multiple HPV infections at baseline. A comparator control group of women who were HPV and cytologically negative at baseline were selected from the same population.
Results: Twelve cases of dyskaryosis were found in women who were HPV positive at baseline; four were high grade. Only three cases of low grade dyskaryosis were found in the control group. Women with type specific persistent infections were significantly more likely to develop cervical neoplasia than women who cleared the infection (p = 0.0001) or were sequentially infected with different types (p = 0.001). Women with multiple HPV infections at baseline were no more likely to develop cervical dyskaryosis than those with a single infection.
Conclusions: Type specific persistent HR-HPV infection as monitored by genotyping can identify women at increased risk of cervical neoplasia more accurately than a single or repeated presence/absence HPV test. The cost effectiveness of such an approach should be investigated by an appropriate, large scale cost-benefit analysis.
Figures
Similar articles
-
Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring.J Med Virol. 2004 May;73(1):65-70. doi: 10.1002/jmv.20062. J Med Virol. 2004. PMID: 15042650
-
Risk factors for cervical neoplasia in Denmark.APMIS Suppl. 1998;80:1-41. APMIS Suppl. 1998. PMID: 9693662
-
Evaluation of type-specific HPV persistence and high-risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytology.J Med Virol. 2011 Apr;83(4):637-43. doi: 10.1002/jmv.22022. J Med Virol. 2011. PMID: 21328378
-
Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.Cancer Epidemiol Biomarkers Prev. 1997 Oct;6(10):807-13. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9332763
-
Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.N Engl J Med. 1999 Nov 25;341(22):1633-8. doi: 10.1056/NEJM199911253412201. N Engl J Med. 1999. PMID: 10572150
Cited by
-
Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium.J Clin Microbiol. 2012 Jan;50(1):25-9. doi: 10.1128/JCM.05400-11. Epub 2011 Nov 16. J Clin Microbiol. 2012. PMID: 22090403 Free PMC article.
-
New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer.Hum Mol Genet. 2008 Jun 15;17(12):1838-44. doi: 10.1093/hmg/ddn077. Epub 2008 Mar 12. Hum Mol Genet. 2008. PMID: 18337305 Free PMC article.
-
HPV genotype distribution and cervical lesions in Chongqing: a comprehensive analysis of 229,770 females (2015‒2023).BMC Infect Dis. 2025 May 27;25(1):760. doi: 10.1186/s12879-025-11128-6. BMC Infect Dis. 2025. PMID: 40426145 Free PMC article.
-
Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories.Infect Agent Cancer. 2007 Jun 5;2:11. doi: 10.1186/1750-9378-2-11. Infect Agent Cancer. 2007. PMID: 17550589 Free PMC article.
-
A comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East Congo.Br J Cancer. 2010 Mar 16;102(6):957-65. doi: 10.1038/sj.bjc.6605594. Epub 2010 Mar 2. Br J Cancer. 2010. PMID: 20197765 Free PMC article.
References
-
- Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423–8. - PubMed
-
- Muñoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518–27. - PubMed
-
- Dalstien V, Riethmuller D, Pretet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003;106:396–403. - PubMed
-
- Bory JP, Cucherousset J, Lorenzato M, et al. Recurrent human papillomavirus infection detected with the hybrid capture 2 assay selects women with normal cervical smears at risk for developing low grade cervical lesions: a longitudinal study of 3091 women. Int J Cancer 2002;102:519–25. - PubMed
-
- Fife KH, Craner HM, Schroeder JM, et al. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 2001;64:550–9. - PubMed